Prot: BN40423: A Randomized, Multicenter, Double-blind, Placebo-Controlled, Phase III Clinica Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Patients with Manifest Huntington's Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date2/7/192/7/21

Funding

  • INC Research, LLC (Prot: BN40423)
  • Genentech, Inc. (Prot: BN40423)